Document is current
Any future updates will be listed below
-
Authors
Pinto, Ana Margarida
Geenen, Rinie
Wager, Tor D. https://orcid.org/0000-0002-1936-5574
Lumley, Mark A.
Häuser, Winfried https://orcid.org/0000-0002-3742-729X
Kosek, Eva
Ablin, Jacob N.
Amris, Kirstine https://orcid.org/0000-0003-0792-505X
Branco, Jaime https://orcid.org/0000-0001-7024-4375
Buskila, Dan
Castelhano, João https://orcid.org/0000-0002-8996-1515
Castelo-Branco, Miguel https://orcid.org/0000-0003-4364-6373
Crofford, Leslie J. https://orcid.org/0000-0002-6347-5738
Fitzcharles, Mary-Ann
López-Solà, Marina
Luís, Mariana
Marques, Tiago Reis https://orcid.org/0000-0003-0602-7661
Mease, Philip J. https://orcid.org/0000-0002-6620-0457
Palavra, Filipe https://orcid.org/0000-0002-2165-130X
Rhudy, Jamie L.
Uddin, Lucina Q. https://orcid.org/0000-0003-2278-8962
Castilho, Paula
Jacobs, Johannes W. G. https://orcid.org/0000-0002-7438-3468
da Silva, José A. P. https://orcid.org/0000-0002-2782-6780
- License Information
-
More Information
Article History
Accepted: 4 November 2022
First Online: 5 December 2022
Competing interests
: E.K. reports personal fees from Eli Lilly, Sandoz and UCB Pharma, outside the submitted work. T.R.M. reports personal fees from Lundbeck, Astellas, Janssen and Angelini outside the submitted work. R.G., T.D.W., M.A.L., W.H., J.N.A., K.A., J.B., D.B., J.C., M.C.-B., L.J.C., M.-A.F., M.L.-S., M.L., P.J.M., F.P., J.L.R., L.Q.U., P.C., J.W.G.J. and J.A.P.S. declare no competing interests.
